NCT04372628 - Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19 | Biotech Hunter

Enrollment

452

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

December 16, 2021

Study Completion Date

January 18, 2022

Conditions

COVID-19

Interventions

DRUG

Lopinavir/Ritonavir 400 mg/100 mg

Lopinavir/Ritonavir tablets

OTHER

Placebo

Unmatched placebo

Trial Locations (6)

Vanderbilt University Medical Center, Nashville

University of Mississippi Medical Center, Jackson

University of Wisconsin, Madison

University of Colorado School of Medicine, Aurora

Intermountain, Murray

Beth Israel Deaconess Medical Center, Boston